JENNIFER NOLLEY: Open Payments
NPI 1306610829 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 59 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,242 · 2025 $1,455
Food & beverage: $1,270Education: $185
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $422 |
| GENZYME CORPORATION | 10 | $162 |
| ABBVIE INC. | 8 | $145 |
| Janssen Biotech, Inc. | 2 | $138 |
| PFIZER INC. | 6 | $124 |
| Novartis Pharmaceuticals Corporation | 4 | $103 |
| Regeneron Healthcare Solutions, Inc. | 3 | $92 |
| Botanix SB Inc | 3 | $62 |
| LEO Pharma Inc. | 2 | $57 |
| UCB, Inc. | 2 | $51 |
Products named: ILUMYA, DUPIXENT, SKYRIZI, TREMFYA, CIBINQO, SOFDRA, ADBRY, Bimzelx.
Industry payments across TX — which companies pay providers there.
